NeoGenomics to Participate at the 22nd Annual Needham Virtual Healthcare Conference
NeoGenomics, Inc. (NASDAQ: NEO), a prominent provider of cancer-focused genetic testing and oncology contract research services, will participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on April 18, 2023, at 11:00am ET. A live audio webcast will be accessible via the Investor Relations section of their website.
NeoGenomics specializes in cancer genetics testing, offering a wide range of testing options to assist healthcare providers in diagnosing and treating cancer. The company also supports pharmaceutical clients through clinical trials and drug development.
Headquartered in Fort Myers, Florida, NeoGenomics operates accredited laboratories across the U.S. and internationally. They are dedicated to connecting patients with transformative therapies while ensuring compliance with data protection laws.
- None.
- None.
FT. MYERS, FL / ACCESSWIRE / April 11, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that members of its management team will participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Tuesday, April 18, 2023 at 11:00am ET.
A live audio webcast of the presentation will be available on the "News, Events, and Webcasts" tab via the Investor Relations section of the Company's website at https://ir.neogenomics.com/.
About NeoGenomics, Inc.
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's Pharma Services Division serves pharmaceutical clients in clinical trials and drug development.
NeoGenomics is committed to connecting patients with life altering therapies and trials. We believe that, together, with our partners, we can help patients with cancer today and the next person diagnosed tomorrow. In carrying out these commitments, NeoGenomics adheres to all relevant data protection laws, provides transparency and choice to patients regarding the handling and use of their data through our Notice of Privacy Practices, and has invested in leading technologies to ensure the data we maintain is secured at all times.
Headquartered in Fort Myers, Florida, NeoGenomics operates CAP accredited and CLIA certified laboratories in Fort Myers and Tampa, Florida; Aliso Viejo, Carlsbad and San Diego, California; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; and CAP accredited laboratories in Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.
CONTACT:
Kendra Sweeney
Vice President, Investor Relations and Communications
M: 239-877-7474
kendra.sweeney@neogenomics.com
SOURCE: NeoGenomics, Inc.
View source version on accesswire.com:
https://www.accesswire.com/748420/NeoGenomics-to-Participate-at-the-22nd-Annual-Needham-Virtual-Healthcare-Conference
FAQ
What is the date and time of NeoGenomics' participation in the 22nd Annual Needham Virtual Healthcare Conference?
Where can I watch the live webcast for NeoGenomics' conference presentation?
What services does NeoGenomics provide?
Where is NeoGenomics headquartered?
What is the main focus of NeoGenomics?
